NanoLogix, Inc. (NNLX)

Market Cap	16.29K -99.6%
Revenue (ttm)	1.27K +139.0%
Net Income	-1.95M
EPS	-0.02
Shares Out	162.89M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	115,587
Average Volume	315,232
Open	0.0001
Previous Close	n/a
Day's Range	0.0001 - 0.0001
52-Week Range	0.0000 - 0.0401
Beta	-32.00
RSI	54.22
Earnings Date	n/a

About NanoLogix

NanoLogix, Inc., a biotechnology company, provides diagnostics of viable microorganisms and viruses. It offers rapid viral assay test, which is a method for detection and quantification of a virus; and N-assay diagnostics that furnish the ability to detect and identify bacteria and other microorganisms for pharmaceutical, industrial, veterinary, and environmental testing, as well as microbiology, soil microbiology and bioremediation, microbial physiology, pharmacology, pharmaco-kinetics, and antibiotic sensitivity sectors. The company sells its...

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Bret Barnhizer
• Employees: 7
• Stock Exchange: OTCMKTS
• Ticker Symbol: NNLX

Financial Performance

In 2011, NanoLogix's revenue was $892, an increase of 39.38% compared to the previous year's $640. Losses were -$1.86 million, -29.93% less than in 2010.